Bladder cancer patients over 70 less likely to get curative treatment

April 17, 2013

(Medical Xpress)—Older bladder cancer patients are less likely than younger patients to receive treatments intended to cure their disease such as surgery to remove the bladder or radiotherapy. But this difference cannot be fully explained by age, according to new research by scientists published in the British Journal of Cancer.

Researchers, funded by Yorkshire at the University of Sheffield, looked at the records of around 3,300 bladder cancer patients diagnosed in Sheffield between 1994 and 2009. They wanted to investigate how age, type of bladder cancer and treatment affected the chances of surviving the disease2.

They found that 52 per cent of patients under 60 had potentially curative treatments such as surgery or radiotherapy, compared with 34 per cent of patients in their 70s and only 12 per cent of patients over 80.

And older patients over 70 were more likely to die of their bladder cancer than younger patients.

The researchers believe that the higher number of deaths in those over 70 is because these patients had a higher proportion of more aggressive tumours and were less likely to receive radical treatments such as or surgery to remove the bladder and nearby organs.

Mr James Catto, study author and consultant urological surgeon at the University of Sheffield, said: "Even though it appears that older patients are more likely to have aggressive tumours, our findings suggest that not enough older patients are being offered treatments that could increase their chance of survival.

"What's very worrying is this conservative approach to treating older patients appears to be affecting the life expectancy of this group, something that doctors must work hard to combat."

Dr Kathryn Scott, head of research funding at Yorkshire Cancer Research, said: "This research shows that the age of bladder in Sheffield greatly affects how they are treated. This has a considerable effect on in elderly patients and Yorkshire, along with the rest of the UK, is going to have to change to address this striking difference."

Sarah Woolnough, executive director of policy and information at Cancer Research UK, said: "This study shows the older the patients are the less likely they are to be offered the kind of treatments that could cure their cancer.

"These decisions are never easy and need to be balanced with quality of life but it's vital for patients of all ages to be given the option of a possible cure when it is still feasible."

Explore further: Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

More information: Noon, A. et al. (2013). Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients British Journal of Cancer DOI: 10.1038/bjc.2013.106

Related Stories

Adding chemo to radiotherapy halves risk of deadly bladder cancer returning

April 23, 2012
(Phys.org) -- Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy ...

Multi-tasking imatinib boosts radiotherapy for bladder tumours

March 4, 2013
Cancer drug imatinib (Glivec) could boost radiotherapy treatment to destroy bladder cancer that has spread to the bladder wall, reveals research published in Cancer Research.

Chemo - radiation best for bladder cancer, study finds

April 19, 2012
(HealthDay) -- The addition of two well-tolerated chemotherapy drugs to radiation therapy led to significantly longer survival rates among patients with muscle-invasive bladder cancer.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.